Depleted Uranium

Alexandra C. Miller is currently a senior scientist and principal investigator at the U.S. Armed Forces Radiobiology Research Institute and the Uniformed Services University of the Health Sciences in Bethesda, Maryland. She received her Bachelor of Science in chemistry from the University of Maryland, College Park, in 1981 and in 1986 she received her doctorate in radiation biology and experimental pathology from Roswell Park Cancer Institute Division at the State University of New York in Buffalo. Dr. Miller completed two postdoctoral projects: the first at the Armed Forces Radiobiology Research Institute in the area of cellular radiobiology and the second at the Uniformed Services University of the Health Sciences in molecular biology and carcinogenesis. She has received training awards from the American Society of Therapeutic Radiation Oncology and the Photo-Radiation Society. Dr. Miller has been a visiting scientist at the National Cancer Institute Division of Cancer Treatment and in France at the University of Paris. Dr. Miller has been nominated for the Radiation Research Society Michael J. Fry Award three times since 1996 and has over 45 peer-reviewed publications. Dr. Miller has received extramural funding from the Henry M. Jackson Foundation for Medical Research, NASA, the U.S. Army Medical Research and Material Command (USAMRMC), and the USAMRMC congressionally directed medical research program. The author has been the principal investigator for more than nine research projects since 1992. She has been an ad hoc member of panels for the World Health Organization, U.S. Army Medical Research Command, U.S. Congressionally Directed Medical Research Programs (CDMRP), U.S. Agency on International Development Committee, and the U.S. Department of Energy. Dr. Miller's research interests include carcinogenesis, transgenerational genotoxicity, chemoprevention, and biodosimetry. Current research projects include heavy metal carcinogenicity, transgenerational genotoxicity, radiation protection against internal radiation emitters and external radiation exposure, chemoprevention of radiationand heavy metal-induced leukemias, and biomarkers of exposure and disease development. Past research focused on molecular genetics of radiation resistance and photodynamic therapy of cancer.